| Title |
Presentation and management of docetaxel-related adverse effects in patients with breast cancer
|
|---|---|
| Published in |
Cancer Management and Research, May 2014
|
| DOI | 10.2147/cmar.s40601 |
| Pubmed ID | |
| Authors |
Maria Y Ho, John R Mackey |
| Abstract |
The taxane chemotherapeutic agent docetaxel has been utilized in the management of breast cancer in the adjuvant, neoadjuvant and metastatic setting. Although well tolerated by the majority of patients, docetaxel toxicity may limit the dose which can be administered. Adverse events include infusion reactions, febrile neutropenia, fatigue, fluid retention, pneumonitis, cutaneous and nail toxicity, epiphora and lacrimal duct stenosis, gastrointestinal complications, and neuropathies. In this review, we explore these complications and how they can be effectively managed to improve patient quality of life during and following docetaxel therapy. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Unknown | 235 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 12% |
| Student > Bachelor | 28 | 12% |
| Student > Ph. D. Student | 27 | 11% |
| Researcher | 15 | 6% |
| Other | 14 | 6% |
| Other | 39 | 17% |
| Unknown | 84 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 29 | 12% |
| Biochemistry, Genetics and Molecular Biology | 21 | 9% |
| Agricultural and Biological Sciences | 17 | 7% |
| Chemistry | 9 | 4% |
| Other | 28 | 12% |
| Unknown | 92 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2016.
All research outputs
#17,438,425
of 25,584,565 outputs
Outputs from Cancer Management and Research
#786
of 2,067 outputs
Outputs of similar age
#146,927
of 242,530 outputs
Outputs of similar age from Cancer Management and Research
#4
of 4 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,067 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,530 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.